SeraSeal – world’s most advanced, next generation hemostatic technology, now in India

SeraSeal™ is an innovative primary haemostatic agent designed to stop bleeding on contact and within seconds for arterial haemorrhages. It is comprised of agar and bovine factor proteins II a VII a and IX a and X a and acts as a catalyst in the clot formation process. This single-component system can tackle any bleeding situation with the potential to save many lives. When seconds count, SeraSeal™ can make the difference between life and death. Ajaypal Singh Randhawa, Founder CEO, Swasth Kare India is hopeful this will bring about a sea-change in the healthcare landscape ‘By reducing blood loss, whole blood units needed, surgical time and tissue conservation, every stage in healthcare will improve. Since saving lives has always been at the forefront of Swasth Kare efforts, Seraseal in the hands of the first responders or surgical theatres will be a huge step in this direction” he commented. The first stage of trauma leads to haemorrhage and inflammation. Haemorrhages lead to shock...